Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)

Research To Practice | Oncology Videos · Apr 16, 2025 · 31m

Featuring a slide presentation and related discussion from Dr Raajit K Rampal, including the following topics:

Overview of the current JAK inhibitor landscape (0:00)

Factors predicting clinical benefit in patients with myelofibrosis (MF) receiving ruxolitinib (3:02)

Clinical data supporting the use of fedratinib after prior ruxolitinib for MF (9:17)

Emerging clinical findings on pelabresib in combination with ruxolitinib for previously untreated MF (12:13)

Available clinical data with novel BET inhibitors (15:00)

Utility of selinexor in combination with ruxolitinib for MF previously treated…